> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
By Tom Winnifrith | Wednesday 13 September 2017
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
This may be the last bearcast you listen to. I hope not. To ensure you can listen to tommorrow's podcast and read two belting exclusives for just £5.99 sign up HERE. Today cover in detail sheer pointlessness of Starvest (SVE) & Torotrak (TRK). Both need to do placings both should, like flea bitten ageing hounds in pain, go on a one way trip to the vet. Once again I apologise to my old friend the offshore based asset stripper Jim Mellon for intruding on private grief as I look at another dog he has backed, Billing Services (BILL)
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |